Your browser doesn't support javascript.
loading
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
BMC Cancer ; 12: 292, 2012 Jul 17.
Article in En | MEDLINE | ID: mdl-22804917

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins / Ras Proteins / MicroRNAs / DNA Copy Number Variations / Mutation Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2012 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins / Ras Proteins / MicroRNAs / DNA Copy Number Variations / Mutation Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2012 Type: Article Affiliation country: Netherlands